The Swarthmore Avenue CVS Pharmacy is the first community pharmacy to reopen in the neighborhood, increasing access to health and wellness essentials WOONSOCKET, R.I., Sept. 19, 2025 /PRNewswire/ — Today, leaders from CVS Health® (NYSE: CVS) were joined […]
Resilience
AVSI Relaunches Proven Poverty Graduation Program in Uganda with $1.5 Million Donor Investment
WASHINGTON, Sept. 19, 2025 /PRNewswire/ — Cost-effective, high-impact projects that enable extremely poor households to escape poverty funded by USAID were terminated earlier this year; one is able to restart thanks to the coordinated efforts […]
FDA Greenlights HDT Bio's First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease
SEATTLE, Sept. 19, 2025 /PRNewswire/ — HDT Bio Corporation, a U.S.-based clinical-stage biotechnology company advancing immune-enhancing solutions for global health, biodefense, and oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared […]
Abbott Declares 407th Consecutive Quarterly Dividend
ABBOTT PARK, Ill., Sept. 19, 2025 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share. This marks the 407th consecutive quarterly dividend to be […]
FDA Grants Orphan Drug Designation to NS-051/NCNP-04 for the Treatment of Duchenne Muscular Dystrophy
PARAMUS, N.J., Sept. 19, 2025 /PRNewswire/ — NS Pharma, Inc. announced today that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to NS-051/NCNP-04 which is being developed for the treatment of […]









